In 2000, Perou et al [29] described the gene expression pattern of invasive BC, thus making it possible to establish molecular classification of BC, currently represented mainly by four subtypes: luminals A and B, HER2, and TN, each with defined characteristic and prognosis. The gene discussed is ERBB2; the disease is breast cancer.